Overview
- K.C. Pharmaceuticals, which disclosed a voluntary recall on March 3, is pulling 3,111,072 bottles across eight eye-drop lines after it could not assure sterility.
- The FDA classified the case as a Class II recall on Tuesday, a category for products that may cause temporary or medically reversible health effects.
- The drops were sold nationwide under store and private labels at chains such as Walgreens, CVS, Kroger, H‑E‑B, Rite Aid and military exchanges.
- Officials report no confirmed contamination or injuries and urge customers to stop use and check lot codes starting with AC, AR, LT, SU, RG, RL, SY or AT.
- The recall remains active with no listed end date, and retailers like CVS say they will accept returns while the manufacturer has not posted a refund program.